Affymetrix (AFFX) Stock Price, News & Analysis

Company Overview

Affymetrix, Inc. (Affymetrix) is a provider of life science products and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level. The Company operates through two business segments: Affymetrix Core and eBioscience. The Affymetrix Core segment focuses on the development, manufacture and commercialization of systems for genetic analysis in the life sciences, agricultural biotechnology (AgBio) and diagnostic industry. The eBioscience segment primarily focuses on the development, manufacture, marketing and distribution of research products in the areas of flow cytometry, immunoassays, microscopic imaging and other protein-based analyses. The Company sells its products to genomic research centers, academic institutions, government and private laboratories, as well as pharmaceutical, diagnostic and biotechnology companies. It maintains sales and distribution operations across the United States, Europe, Latin America and Asia.

Key Stats

• Today's Range: $14.01 to $14.01
• 50-Day Range: N/A
• 52-Week Range: $8.28 to $16.15
• Volume: N/A
• Average Volume: 3.49 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AFFX Stock Analysis - Frequently Asked Questions

How were Affymetrix's earnings last quarter?

Affymetrix Inc (NASDAQ:AFFX) issued its quarterly earnings data on Wednesday, February, 17th. The scientific and technical instruments company reported $0.09 EPS for the quarter, missing analysts' consensus estimates of $0.11 by $0.02. The scientific and technical instruments company had revenue of $95.60 million for the quarter, compared to analyst estimates of $93.29 million.

What other stocks do shareholders of Affymetrix own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Affymetrix investors own include Orchid Island Capital (ORC), XOMA Royalty (xoma), Alnylam Pharmaceuticals (ALNY), Ascent Solar Technologies (ASTI), Meta Platforms (META), ACADIA Pharmaceuticals (ACAD) and Intel (INTC).

Company Calendar

• Last Earnings: 2/17/2016
• Today: 8/18/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: NASDAQ:AFFX
• CIK: 913077
• Web: www.affymetrix.com
• Phone: +1-408-7315000
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A